Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghav Sundar

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Cancer Discovery|January 10, 2018
Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?Raghav Sundar, Patrick Tan
The Surgical Clinics of North America|November 10, 2024
Multimodality Treatment for Locally Advanced Gastric AdenocarcinomaThejal Srikumar, Raghav Sundar
BMJ Case Reports|March 10, 2015
Zinner syndrome: an uncommon cause of painful ejaculationRaghav Sundar, Gaurav Sundar
Therapeutic Advances in Medical Oncology|February 19, 2026
Illustrating a multidimensional roadmap using biomarkers and therapeutics to reshape outcomes in gastroesophageal cancerPrashanth Moku, Raghav Sundar
Nature Medicine|August 19, 2025
Evolution of claudin18.2 therapies in gastroesophageal cancersSamuel J Klempner, Raghav Sundar
The Lancet. Gastroenterology & Hepatology|March 16, 2024
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancerRaghav Sundar, Elizabeth C Smyth
Gastroenterology|January 17, 2025
ReplyJoseph J Zhao, Raghav Sundar
Lancet (London, England)|October 23, 2023
Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancerElizabeth C Smyth, Raghav Sundar
JAMA|February 24, 2025
PD-1 or PD-L1-A Difference That Makes No Difference?Samuel J Klempner, Jeeyun Lee, Raghav Sundar
JAMA Oncology|May 11, 2023
Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma-ReplyJoseph J Zhao, Filippo Pietrantonio, Raghav Sundar
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Cancer Discovery|January 10, 2018
Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?Raghav Sundar, Patrick Tan
The Surgical Clinics of North America|November 10, 2024
Multimodality Treatment for Locally Advanced Gastric AdenocarcinomaThejal Srikumar, Raghav Sundar
BMJ Case Reports|March 10, 2015
Zinner syndrome: an uncommon cause of painful ejaculationRaghav Sundar, Gaurav Sundar
Therapeutic Advances in Medical Oncology|February 19, 2026
Illustrating a multidimensional roadmap using biomarkers and therapeutics to reshape outcomes in gastroesophageal cancerPrashanth Moku, Raghav Sundar
Nature Medicine|August 19, 2025
Evolution of claudin18.2 therapies in gastroesophageal cancersSamuel J Klempner, Raghav Sundar
The Lancet. Gastroenterology & Hepatology|March 16, 2024
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancerRaghav Sundar, Elizabeth C Smyth
Gastroenterology|January 17, 2025
ReplyJoseph J Zhao, Raghav Sundar
Lancet (London, England)|October 23, 2023
Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancerElizabeth C Smyth, Raghav Sundar
JAMA|February 24, 2025
PD-1 or PD-L1-A Difference That Makes No Difference?Samuel J Klempner, Jeeyun Lee, Raghav Sundar
JAMA Oncology|May 11, 2023
Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma-ReplyJoseph J Zhao, Filippo Pietrantonio, Raghav Sundar
Pageof 15